4524

MORISHITA JINTAN CO.,LTD.

森下仁丹株式会社
Pharmaceutical
Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health foods in Japan. The company offers health food products, oral care product, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shop; domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200 and Bifidobacterium Pearl products through medical institutions. In addition, the company offers OEM contract services. Further, it develops Jintan capsule technology that allows encapsulating various contents, such as powder, liquid, microbe or others. Morishita Jintan Co., Ltd. was founded in 1893 and is headquartered in Chuo, Japan.
← Companies
Price
¥2,160
Market Cap
¥8.8B
Ent. Value
¥8.3B
Net Cash
¥584M
Shares Out.
4.1M
P / E
16.1×
EV / EBIT
10.3×
P / Book
0.73×
P / NCAV
3.62×
Div. Yield
2.55%
Financials
Metric FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥12.8B ¥12.4B ¥11.4B ¥9.6B
Cost of Sales ¥6.8B ¥6.4B ¥6.0B ¥4.7B
Gross Profit ¥6.0B ¥6.0B ¥5.3B ¥4.9B
SG&A ¥5.2B ¥5.3B ¥4.7B ¥4.6B
Operating Income ¥804M ¥716M ¥569M ¥299M
Non-Operating Income ¥77M ¥102M ¥57M ¥49M
Dividend Income ¥72M ¥63M ¥46M ¥44M
Interest Income ¥0M ¥0M ¥0M ¥1M
Non-Operating Expenses ¥10M ¥2M ¥3M ¥8M
Interest Expense ¥8M ¥2M ¥2M ¥7M
Ordinary Income ¥870M ¥815M ¥623M ¥340M
Pre-tax Income ¥772M ¥820M ¥623M ¥385M
Income Taxes ¥225M ¥123M ¥131M ¥101M
Current Tax ¥111M ¥263M ¥176M ¥72M
Deferred Tax ¥114M ¥-139M ¥-45M ¥29M
Net Income (owners) ¥547M ¥697M ¥491M ¥283M
Comprehensive Income ¥200M ¥908M ¥1.1B ¥327M
EBITDA ¥1.4B ¥1.3B ¥1.2B ¥884M
EPS ¥133.78 ¥170.68 ¥120.55 ¥69.58
Shares Outstanding 4.1M 4.1M 4.1M 4.1M
Shares Issued (total) 4.2M 4.2M 4.2M 4.2M
Treasury Shares 0.1M 0.1M 0.1M 0.1M